Here's how Patients can currently pay $400 a month for popular weight-loss drug Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January
Prog Cardiovasc Dis (2018) 61(2):10313
Semaglutide is a ground-breaking medication in the weight loss arena
FDA-approved for type 2 diabetes treatment in 2017 and administered via a once-a-week injection, Semaglutide, have emerged as miracles for many individuals who've battled lifelong weight issues
It has the widest GLP-1 menu we have tested and a clinical operation that checks every basic safety box, but pricing transparency gaps and a BBB pattern-of-complaints alert pull the grade out of A territory
Retatrutide at 12 mg weekly currently produces the largest weight loss of any published Phase 3 GLP-1-class compound, exceeding tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints